Physician profile
Bisher A Abdullah
NPI 1235161712
$6,211.25
in general payments reported to CMS, 2019-2025
35 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 83% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $264 · 2021: $929 · 2022: $1,225 · 2023: $928 · 2024: $861 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,804 · Gift: $79.69 · Consulting Fee: $30.57 · Education: $24.14 · Debt Forgiveness: $21.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,804.28 |
| Gift | $79.69 |
| Consulting Fee | $30.57 |
| Education | $24.14 |
| Debt Forgiveness | $21.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,840.89 | 2019-2025 | Mavyret, Rinvoq, Linzess |
| Alexion Pharmaceuticals, INC. | $388.01 | 2019-2023 | Strensiq |
| Takeda Pharmaceuticals U.S.A., INC. | $335.65 | 2021-2025 | Eohilia, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $279.42 | 2024-2025 | Xifaxan |
| Genzyme Corporation | $256.15 | 2022-2024 | |
| Ethicon US, LLC | $236.50 | 2019 | |
| Nestle Healthcare Nutrition INC. | $177.29 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $175.11 | 2022-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $154.78 | 2019-2023 | Dificid |
| Pfizer INC. | $148.11 | 2020-2021 | |
| Braintree Laboratories, INC. | $132.62 | 2022-2024 | Sutab, Suflave |
| Phadia US INC. | $129.14 | 2021-2024 | Immunocap |
| Qol Medical, LLC | $115.96 | 2021-2023 | Sucraid |
| Apollo Endosurgery US INC | $81.65 | 2019 | |
| Janssen Biotech, INC. | $79.80 | 2024-2025 | Tremfya, Stelara, Talvey |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $79.39 | 2024-2025 | Daybue |
| Celltrion USA INC. | $78.11 | 2024-2025 | Vegzelma, Zymfentra |
| Lumendi LLC | $58.50 | 2023-2024 | Dilumen Ez1, 103 Cm, Dilumen Ez1, 130 Cm |
| Alfasigma USA, INC. | $55.48 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $45.80 | 2024-2025 | Iqirvo, Bylvay |
| Rhythm Pharmaceuticals, INC. | $34.02 | 2023 | Imcivree |
| Adma Biomanufacturing LLC | $30.57 | 2023 | |
| Travere Therapeutics, INC. | $29.98 | 2023 | Cholbam |
| Aimmune Therapeutics, INC. | $29.66 | 2025 | Zenpep |
| Organon LLC | $29.00 | 2023 | Renflexis |
| Azurity Pharmaceuticals, INC. | $28.45 | 2025 | Sutab |
| Madrigal Pharmaceuticals | $27.23 | 2025 | Rezdiffra |
| Novo Nordisk INC | $24.08 | 2025 | Wegovy |
| Olympus America INC. | $21.75 | 2025 | Evis Exera III Colonovideoscope |
| Pharming Healthcare, INC. | $21.20 | 2024 | Ruconest |
| Digestive Care, INC. | $21.13 | 2025 | Pertzye |
| Bardy Diagnostics, INC. | $19.45 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.72 | 2023 | |
| Strongbridge US INC. | $14.88 | 2019 | |
| Cook Medical LLC | $14.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bisher Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.